Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

NASDAQ:OLPX - Nasdaq - US6793691089 - Common Stock - Currency: USD

1.56  -0.03 (-1.89%)

After market: 1.56 0 (0%)

Fundamental Rating

6

Taking everything into account, OLPX scores 6 out of 10 in our fundamental rating. OLPX was compared to 37 industry peers in the Personal Care Products industry. OLPX has an excellent profitability rating, but there are some minor concerns on its financial health. OLPX may be a bit undervalued, certainly considering the very reasonable score on growth This makes OLPX very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year OLPX was profitable.
OLPX had a positive operating cash flow in the past year.
OLPX had positive earnings in each of the past 5 years.
Each year in the past 5 years OLPX had a positive operating cash flow.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 100M 200M 300M

1.2 Ratios

The Return On Assets of OLPX (2.41%) is comparable to the rest of the industry.
OLPX has a better Return On Equity (4.82%) than 63.89% of its industry peers.
OLPX has a Return On Invested Capital (3.95%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for OLPX is in line with the industry average of 13.52%.
The 3 year average ROIC (14.05%) for OLPX is well above the current ROIC(3.95%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.41%
ROE 4.82%
ROIC 3.95%
ROA(3y)10.69%
ROA(5y)50.35%
ROE(3y)26.89%
ROE(5y)83.81%
ROIC(3y)14.05%
ROIC(5y)95.91%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 100 200 300 400

1.3 Margins

OLPX has a Profit Margin of 9.78%. This is amongst the best in the industry. OLPX outperforms 80.56% of its industry peers.
OLPX's Profit Margin has been stable in the last couple of years.
OLPX has a better Operating Margin (19.38%) than 88.89% of its industry peers.
In the last couple of years the Operating Margin of OLPX has declined.
OLPX's Gross Margin of 70.40% is fine compared to the rest of the industry. OLPX outperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of OLPX has grown nicely.
Industry RankSector Rank
OM 19.38%
PM (TTM) 9.78%
GM 70.4%
OM growth 3Y-13.39%
OM growth 5YN/A
PM growth 3Y-1.17%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5YN/A
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 20 40 60

6

2. Health

2.1 Basic Checks

OLPX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for OLPX has been increased compared to 1 year ago.
The debt/assets ratio for OLPX has been reduced compared to a year ago.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

OLPX has an Altman-Z score of 1.97. This is not the best score and indicates that OLPX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.97, OLPX is in line with its industry, outperforming 41.67% of the companies in the same industry.
OLPX has a debt to FCF ratio of 4.71. This is a neutral value as OLPX would need 4.71 years to pay back of all of its debts.
OLPX has a better Debt to FCF ratio (4.71) than 63.89% of its industry peers.
OLPX has a Debt/Equity ratio of 0.73. This is a neutral value indicating OLPX is somewhat dependend on debt financing.
OLPX's Debt to Equity ratio of 0.73 is on the low side compared to the rest of the industry. OLPX is outperformed by 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 4.71
Altman-Z 1.97
ROIC/WACC0.47
WACC8.41%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 11.84. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX's Current ratio of 11.84 is amongst the best of the industry. OLPX outperforms 100.00% of its industry peers.
A Quick Ratio of 10.32 indicates that OLPX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 10.32, OLPX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.84
Quick Ratio 10.32
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for OLPX have decreased strongly by -35.00% in the last year.
The Earnings Per Share has been growing by 14.85% on average over the past years. This is quite good.
The Revenue has decreased by -9.15% in the past year.
Measured over the past years, OLPX shows a quite strong growth in Revenue. The Revenue has been growing by 17.53% on average per year.
EPS 1Y (TTM)-35%
EPS 3Y14.85%
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y17.53%
Revenue growth 5YN/A
Sales Q2Q%-3.62%

3.2 Future

Based on estimates for the next years, OLPX will show a decrease in Earnings Per Share. The EPS will decrease by -2.80% on average per year.
The Revenue is expected to grow by 20.75% on average over the next years. This is a very strong growth
EPS Next Y-31.79%
EPS Next 2Y-15.01%
EPS Next 3Y-15.69%
EPS Next 5Y-2.8%
Revenue Next Year-10.02%
Revenue Next 2Y-6.22%
Revenue Next 3Y-3.4%
Revenue Next 5Y20.75%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.00, the valuation of OLPX can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of OLPX indicates a rather cheap valuation: OLPX is cheaper than 86.11% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.46. OLPX is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 13.50, OLPX is valued correctly.
Based on the Price/Forward Earnings ratio, OLPX is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OLPX to the average of the S&P500 Index (92.56), we can say OLPX is valued rather cheaply.
Industry RankSector Rank
PE 12
Fwd PE 13.5
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than OLPX, based on the Enterprise Value to EBITDA ratio.
91.67% of the companies in the same industry are more expensive than OLPX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.47
EV/EBITDA 8.37
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

OLPX has a very decent profitability rating, which may justify a higher PE ratio.
OLPX's earnings are expected to decrease with -15.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.01%
EPS Next 3Y-15.69%

0

5. Dividend

5.1 Amount

OLPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (1/31/2025, 8:00:02 PM)

After market: 1.56 0 (0%)

1.56

-0.03 (-1.89%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-26 2025-02-26/amc
Inst Owners18.88%
Inst Owner Change-0.02%
Ins Owners1.6%
Ins Owner Change18.86%
Market Cap1.03B
Analysts52
Price Target2.19 (40.38%)
Short Float %9.25%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.67%
Min EPS beat(2)-9.37%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)-1.64%
Min EPS beat(4)-9.37%
Max EPS beat(4)3.93%
EPS beat(8)5
Avg EPS beat(8)2.02%
EPS beat(12)9
Avg EPS beat(12)4.08%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.57%
Min Revenue beat(2)-7.47%
Max Revenue beat(2)-1.68%
Revenue beat(4)2
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)1.8%
Revenue beat(8)4
Avg Revenue beat(8)-3.36%
Revenue beat(12)7
Avg Revenue beat(12)-1.35%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.83%
PT rev (3m)-16.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-84.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-26.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.01%
Valuation
Industry RankSector Rank
PE 12
Fwd PE 13.5
P/S 2.38
P/FCF 7.47
P/OCF 7.26
P/B 1.18
P/tB N/A
EV/EBITDA 8.37
EPS(TTM)0.13
EY8.33%
EPS(NY)0.12
Fwd EY7.41%
FCF(TTM)0.21
FCFY13.38%
OCF(TTM)0.21
OCFY13.77%
SpS0.65
BVpS1.33
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 4.82%
ROCE 4.94%
ROIC 3.95%
ROICexc 5.79%
ROICexgc 80.17%
OM 19.38%
PM (TTM) 9.78%
GM 70.4%
FCFM 31.91%
ROA(3y)10.69%
ROA(5y)50.35%
ROE(3y)26.89%
ROE(5y)83.81%
ROIC(3y)14.05%
ROIC(5y)95.91%
ROICexc(3y)17.07%
ROICexc(5y)115.89%
ROICexgc(3y)197.06%
ROICexgc(5y)338.85%
ROCE(3y)17.53%
ROCE(5y)119.73%
ROICexcg growth 3Y-46.96%
ROICexcg growth 5YN/A
ROICexc growth 3Y3.36%
ROICexc growth 5YN/A
OM growth 3Y-13.39%
OM growth 5YN/A
PM growth 3Y-1.17%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 4.71
Debt/EBITDA 4.71
Cap/Depr 7.71%
Cap/Sales 0.94%
Interest Coverage 1.38
Cash Conversion 103.97%
Profit Quality 326.14%
Current Ratio 11.84
Quick Ratio 10.32
Altman-Z 1.97
F-Score6
WACC8.41%
ROIC/WACC0.47
Cap/Depr(3y)5.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.49%
Cap/Sales(5y)0.29%
Profit Quality(3y)158.55%
Profit Quality(5y)178.05%
High Growth Momentum
Growth
EPS 1Y (TTM)-35%
EPS 3Y14.85%
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-31.79%
EPS Next 2Y-15.01%
EPS Next 3Y-15.69%
EPS Next 5Y-2.8%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y17.53%
Revenue growth 5YN/A
Sales Q2Q%-3.62%
Revenue Next Year-10.02%
Revenue Next 2Y-6.22%
Revenue Next 3Y-3.4%
Revenue Next 5Y20.75%
EBIT growth 1Y-39.14%
EBIT growth 3Y1.79%
EBIT growth 5YN/A
EBIT Next Year-15.98%
EBIT Next 3Y-7.26%
EBIT Next 5Y-0.99%
FCF growth 1Y-44.41%
FCF growth 3Y10.47%
FCF growth 5YN/A
OCF growth 1Y-43.36%
OCF growth 3Y11.23%
OCF growth 5YN/A